Literature DB >> 26086335

Social determinants of lung cancer incidence in Canada: A 13-year prospective study.

Debjani Mitra1, Amanda Shaw1, Michael Tjepkema2, Paul Peters3.   

Abstract

BACKGROUND: The risk of lung cancer has been shown to be inversely related to socioeconomic status (SES). Because the Canadian Cancer Registry does not contain socioeconomic data, the 1991 Canadian Census Cohort was used to study social determinants of lung cancer risk in the general Canadian population. DATA AND METHODS: This study examines incidence rates of lung cancer and histologic subtypes by educational attainment, income and occupation in a broadly representative sample of Canadians aged 25 or older. Data for the 1991 Canadian Census Cohort were analyzed. The cohort comprised 2,734,835 individuals, among whom 215,700 new cancer cases were diagnosed from 1991 through 2003. Age-standardized incidence rates were calculated by age, sex, and SES using the direct method. Rate ratios, rate differences, and excess incidence were also calculated.
RESULTS: An inverse risk between lung cancer incidence and educational attainment, income and occupation emerged among men and women, and a stepped negative gradient in RRs was evident for all SES variables and age groups. If all cohort members had experienced the rate of those with a university degree, lung cancer incidence would have been 56% lower in men and 55% lower in women. If all cohort members had experienced the incidence rate of those in the highest income quintile, incidence would have been 33% lower in men and 25% lower in women. If all cohort members had experienced the rate of those in managerial occupations, incidence would have been 54% lower in men and 44% lower in women.
INTERPRETATION: A negative gradient in lung cancer risk was evident for all SES variables studied.

Entities:  

Keywords:  Age-standardized incidence rates; longitudinal study; lung cancer; record linkage; social determinants of health; socioeconomic inequalities

Mesh:

Year:  2015        PMID: 26086335

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  14 in total

1.  Preliminary Evaluation of a Citizen Scientist Educational Curriculum Aimed at Engaging Black Men in Lung Cancer Early Detection Screening.

Authors:  Alicia K Matthews; Marcus Murray; Josef Ben Levi; David Odell; Rohan Jeremiah; LeAndre Moore; Damilola Oyaluade; Alexis Chappel; Larisa Burke; Karriem Watson
Journal:  Am J Mens Health       Date:  2022 May-Jun

2.  Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening.

Authors:  Ambreen Sayani; Mandana Vahabi; Mary Ann O'Brien; Geoffrey Liu; Stephen Hwang; Peter Selby; Erika Nicholson; Meredith Giuliani; Lawson Eng; Aisha Lofters
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

3.  Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba.

Authors:  David E Dawe; Harminder Singh; Lahiru Wickramasinghe; Marshall W Pitz; Mahmoud Torabi
Journal:  Can Respir J       Date:  2017-06-21       Impact factor: 2.409

4.  Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.

Authors:  Shih-Feng Liu; Ho-Chang Kuo; Meng-Chih Lin; Shu-Chen Ho; Mei-Lien Tu; Yu-Mu Chen; Yung-Che Chen; Wen-Feng Fang; Chin-Chou Wang; Guan-Heng Liu
Journal:  Oncotarget       Date:  2017-05-02

5.  Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine.

Authors:  Xiaofang Wang; Yan Zhang; Shiying Hao; Xuefeng B Ling; Le Zheng; Jiayu Liao; Chengyin Ye; Minjie Xia; Oliver Wang; Modi Liu; Ching Ho Weng; Son Q Duong; Bo Jin; Shaun T Alfreds; Frank Stearns; Laura Kanov; Karl G Sylvester; Eric Widen; Doff B McElhinney
Journal:  J Med Internet Res       Date:  2019-05-16       Impact factor: 5.428

6.  Community economic factors influence outcomes for patients with primary malignant glioma.

Authors:  Aaron Bower; Fang-Chi Hsu; Kathryn E Weaver; Caleb Yelton; Rebecca Merrill; Robert Wicks; Mike Soike; Angelica Hutchinson; Emory McTyre; Adrian Laxton; Stephen Tatter; Christina Cramer; Michael Chan; Glenn Lesser; Roy E Strowd
Journal:  Neurooncol Pract       Date:  2020-03-24

7.  A modifiable risk factors atlas of lung cancer: A Mendelian randomization study.

Authors:  Jiayi Shen; Huaqiang Zhou; Jiaqing Liu; Yaxiong Zhang; Ting Zhou; Yunpeng Yang; Wenfeng Fang; Yan Huang; Li Zhang
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

8.  Building on existing tools to improve chronic disease prevention and screening in public health: a cluster randomized trial.

Authors:  A K Lofters; M A O'Brien; R Sutradhar; A D Pinto; N N Baxter; P Donnelly; R Elliott; R H Glazier; J Huizinga; R Kyle; D M Manca; M A Pietrusiak; L Rabeneck; B Riordan; P Selby; K Sivayoganathan; C Snider; N Sopcak; K Thorpe; J Tinmouth; B Wall; F Zuo; E Grunfeld; L Paszat
Journal:  BMC Public Health       Date:  2021-08-03       Impact factor: 3.295

9.  Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting.

Authors:  Michael C Repka; Nima Aghdam; Andrew W Karlin; Keith R Unger
Journal:  Cancer Med       Date:  2017-10-04       Impact factor: 4.452

10.  Are there social gradients in the occurrence of lung cancer and in the survival of lung cancer patients? Findings from an observational study using German claims data of Lower Saxony.

Authors:  Sebastian Schröder; Johannes Beller; Heiko Golpon; Siegfried Geyer
Journal:  BMJ Open       Date:  2020-09-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.